Thus, E7-specific CD8 T cell response in blood, spleen, and bone marrow were measured 45 days post TC-1 tumor implantation in KVK-vaccinated mice receiving NKG2A blockade therapy. The gene discussed is CD8A; the disease is neoplasm.